Correlation Between MAIA Biotechnology and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both MAIA Biotechnology and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MAIA Biotechnology and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MAIA Biotechnology and Lumos Pharma, you can compare the effects of market volatilities on MAIA Biotechnology and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MAIA Biotechnology with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of MAIA Biotechnology and Lumos Pharma.
Diversification Opportunities for MAIA Biotechnology and Lumos Pharma
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between MAIA and Lumos is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and MAIA Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MAIA Biotechnology are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of MAIA Biotechnology i.e., MAIA Biotechnology and Lumos Pharma go up and down completely randomly.
Pair Corralation between MAIA Biotechnology and Lumos Pharma
Given the investment horizon of 90 days MAIA Biotechnology is expected to under-perform the Lumos Pharma. In addition to that, MAIA Biotechnology is 5.7 times more volatile than Lumos Pharma. It trades about -0.13 of its total potential returns per unit of risk. Lumos Pharma is currently generating about -0.02 per unit of volatility. If you would invest 436.00 in Lumos Pharma on August 24, 2024 and sell it today you would lose (3.00) from holding Lumos Pharma or give up 0.69% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
MAIA Biotechnology vs. Lumos Pharma
Performance |
Timeline |
MAIA Biotechnology |
Lumos Pharma |
MAIA Biotechnology and Lumos Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MAIA Biotechnology and Lumos Pharma
The main advantage of trading using opposite MAIA Biotechnology and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MAIA Biotechnology position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Eliem Therapeutics | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |